美国 · SEC FORM 4
Repare Therapeutics Inc.
RPTX · — · CIK 0001808158 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2023-11-16 · BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N · $1.6M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-11-16 · BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N.
近期 Form 4 活动
0买入
0卖出
8其他 Form 4 交易行
6SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-11-16 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 295,745 | USD 5.38 | USD 1,591,108 | SEC 申报 ↗ |
| 2023-11-15 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 931,556 | USD 5.00 | USD 4,657,780 | SEC 申报 ↗ |
| 2023-11-02 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 783,709 | USD 3.60 | USD 2,821,352 | SEC 申报 ↗ |
| 2022-06-13 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 149,161 | USD 12.73 | USD 1,898,820 | SEC 申报 ↗ |
| 2022-06-06 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 6,869 | USD 13.21 | USD 90,739 | SEC 申报 ↗ |
| 2022-06-03 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 644,044 | USD 12.29 | USD 7,915,301 | SEC 申报 ↗ |
| 2022-06-02 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 1,186,045 | USD 11.68 | USD 13,853,006 | SEC 申报 ↗ |
| 2022-05-18 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 420,000 | USD 8.50 | USD 3,570,000 | SEC 申报 ↗ |
| 2022-01-19 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | 买入 (P) | Common Shares, no par value | 997,961 | USD 14.10 | USD 14,071,250 | SEC 申报 ↗ |
| 2021-11-16 | Civik Thomas | 买入 (P) | Common Shares | 7,500 | USD 28.08 | USD 210,600 | SEC 申报 ↗ |
| 2020-06-23 | Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P. | 买入 (P) | Common Shares | 250,000 | USD 20.00 | USD 5,000,000 | SEC 申报 ↗ |
| 2020-06-23 | Versant Affiliates Fund V, L.P.; Versant Ophthalmic Affiliates I, L.P.; Versant Venture Capital V (Canada), LP; Versant Venture Capital V, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures V (Canada), L.P.; Versant Ventures V GP-GP (Canada), Inc.; Versant Ventures V, LLC; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC | 买入 (P) | Common Shares | 250,000 | USD 20.00 | USD 5,000,000 | SEC 申报 ↗ |
| 2020-06-23 | Segal Lloyd Mitchell | 买入 (P) | Common Stock | 5,000 | USD 20.00 | USD 100,000 | SEC 申报 ↗ |
| 2020-06-23 | SCHAFER CAROL | 买入 (P) | Common Shares | 8,000 | USD 20.00 | USD 160,000 | SEC 申报 ↗ |
| 2020-06-23 | RHOADS ANN D | 买入 (P) | Common Shares | 4,000 | USD 20.00 | USD 80,000 | SEC 申报 ↗ |
Form 4 申报证据
8 transaction lines in the latest 365-day window; 585 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-28 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | U (U) | Common Shares, no par value | 10,166,943 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | SCHAFER CAROL | D (D) | Common Shares | 8,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | RHOADS ANN D | D (D) | Common Shares | 4,000 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (6 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-28 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | U (U) | Common Shares, no par value | 10,166,943 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | SCHAFER CAROL | D (D) | Common Shares | 8,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | RHOADS ANN D | D (D) | Common Shares | 4,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | Forte Steve | D (D) | Common Shares | 56,786 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | Civik Thomas | D (D) | Common Shares | 7,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-28 | Alves Sandra Isabelle Barros | D (D) | Common Shares | 31,622 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RPTX |
| CIK | 0001808158 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 585 transaction lines from 2020-06-23 to 2026-01-28 46 P purchase lines · 232 S sale lines · 307 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.